602306-29-6

 Home / Products / Inhibitors / CDK inhibitors / 602306-29-6
4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺

602306-29-6

Cat.No.ABP000849 Chemical Name4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺 MolFormulaC18H21N5O2S MolWeight371.457 Purity >99 %

Chemical Name : 4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺

CAS : 602306-29-6

Synonyms: 4-[2-甲基-1-异丙基-1H-咪唑-5-基]-N-[4-(甲磺酰基)苯基]-2-嘧啶胺

溶解度:DMSO

储存条件:-20℃ 2 years

生物活性

Nanomolar concentrations of flavopiridol inhibited rhabdoid cell growth (IC50-200nmol/L) , induced G1and G2 arrest, and apoptosis in vitro in a concentration-dependent manner. These effects were correlated with the down-modulation of cyclin D1, up-regulation of p21, and induction of caspase 3/7 activities. Flavopiridol (at 7.5 mg/kg) significantly inhibited the growth of xenografted rhabdoid tumors, and its effect was correlated with the induction of p21 and down-modulation of cyclin D1. [2]
Exposure of HNSCC cells to flavopiridol diminished cdc2 and cdk2 activity and potently inhibited cell proliferation (IC50=43-83 nM), which was concomitant with the appearance of cells with a sub-G1 DNA content. [3]

参考文献

[1] Lloyd R Kelland . Expert Opinion on Investigational Drugs. 2000 December;9(12):2903-2911

[2] Melissa E. Smith et al. Clin Cancer Res.2008 January 15;14:523-532

[3] Vyomesh Patel et al. The Journal of Clinical Investigation. 1998 November;102(9):1674-1681      

Enquiry